Substance misuse in patients with schizophrenia: Epidemiology and management

Abstract

The second half of the 20th century saw both the deinstitutionalisation movement in Western psychiatry and a substantial increase in the use of many psychoactive substances - a trend that has not yet peaked. Comorbid substance-use disorders in individuals with schizophrenia are now very common. How should such patients be managed